JUL 03, 2015 8:34 AM PDT

This will only hurt a little! Challenging the Theranos revolution

WRITTEN BY: Kerry Evans
Theranos, founded in 2003 by Elizabeth Holmes, plans to revolutionize clinical laboratory testing by offering low cost blood tests at neighborhood drug stores. Eleftherios Diamandis, head of clinical biochemistry at Mount Sinai Hospital in Toronto, thinks this is too good to be true. He challenges the Theranos model in a recent issue of Clinical Chemistry and Laboratory Medicine.

Theranos offers low cost, direct-to-consumer, laboratory testing.
Theranos testing requires just a few microliters of blood, and more than 30 tests can be performed on a single sample, according to Holmes. Blood is collected from the finger into a disposable cartridge, and loaded into a reader for analysis. However, according to Diamandis, this technology has not been independently evaluated, and no results have been shared in peer-reviewed scientific literature.

Theranos claims to offer the same services as a centralized laboratory, but at a fraction of the cost. Diamandis, however, suspects the cost of reagents and consumables to be similar, if not lower, at centralized labs. Theranos insists that a separate vial of blood is required by centralized labs to perform each blood test. Diamandis disagrees, noting that 10 to 100 analytes can be measured on a 7 ml sample of blood with current (low cost) technology.

Above all, Diamandis is most concerned about the public ordering and interpreting their own blood tests, citing a "lack of appreciation of the dangers of self-screening and self-interpretation of results by asymptomatic individuals who are trying to detect occult disease". What's more, centralized labs phased out the multi-parametric panels used by Theranos in the 1980s because they carry a high rate of false positive results.

Diamandis concludes his critique with a call to openly discuss the Theranos approach in the scientific literature. However, he maintains, "their claims of superiority over current systems and practices are speculative, at best".



Sources: Clinical Chemistry and Laboratory Medicine (CCLM). Volume 53, Issue 7, Pages 989-993 DOI: 10.1515/cclm-2015-0356, May 2015, Business Insider, EurekAlert, EmpowHER, Theranos
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
SEP 25, 2020
Health & Medicine
Does Cannabis Affect Brain Health in Older People?
SEP 25, 2020
Does Cannabis Affect Brain Health in Older People?
Demographic data shows rising cannabis use among older people, so what is the likely effect on cognitive funct ...
OCT 06, 2020
Immunology
COVID Triggers Abnormalities in Immune Monocytes
OCT 06, 2020
COVID Triggers Abnormalities in Immune Monocytes
University of Manchester immunologists are the first to make an interesting observation about the white blood cells of p ...
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 15, 2020
Microbiology
WHO Data Suggests Remdesivir Has No Effect on COVID-19 Infections
OCT 15, 2020
WHO Data Suggests Remdesivir Has No Effect on COVID-19 Infections
While the study has not yet been peer-reviewed, an International consortium including researchers has come to the conclu ...
OCT 18, 2020
Cell & Molecular Biology
Small RNA is Connected to Bacterial Pathogenicity
OCT 18, 2020
Small RNA is Connected to Bacterial Pathogenicity
It's thought that as much as half of the global population carries a bacterium called Helicobacter pylori in their stoma ...
Loading Comments...